Bacil Pharma Ltd.

BSE: 524516

₹12.00

up-down-arrow0.57 (4.99%)

As on 28-Aug-2026IST

Market cap

info icon

₹17 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

26.2

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Bacil Pharma Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 11.23 High: 12.00

52 Week Range

Low: 10.65 High: 61.80

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹1 Cr

  • ROEROE information

    3.2 %

  • ROCEROCE information

    3 %

  • Industry P/EIndustry P/E information

    39.9

  • EV/EBITDAEV/EBITDA information

    102.8

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹17.5

  • EPSEPS information

    ₹0.5

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    14,353,000

10 Years Aggregate

CFO

₹-3.34 Cr

EBITDA

₹-6.33 Cr

Net Profit

₹-8.33 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Bacil Pharma
-66.3 -55.2 -76.5 -67.5 13.4 -- 8.6
BSE Healthcare
18.8 2.8 8.7 17.1 23.1 14.8 12.4
As on 28-Aug-2026
Company
2025
2024
2023
2022
2021
2020
2019
Bacil Pharma
-33.1 736.0 -31.7 31.5 51.0 148.4 -13.4
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Bacil Pharma
12.0 17.2 0.0 0.7 -- 2.6 26.2 0.7
3,281.6 26,870.9 1,461.8 387.4 34.5 25.2 69.6 15.5
813.5 16,000.2 7,784.0 688.5 10.6 14 23.1 2.7
449.9 17,241.8 2,141.5 58.5 5.8 3.3 162.3 4.5
836.7 20,739.4 5,632.3 662.4 17.2 14.3 31.3 4.2
1,532.2 17,579.4 1,543.3 -48.6 3.6 -0.6 -- 3.0
218.7 29,103.3 9,205.3 -371.8 1.7 -3.8 -- 3.6
1,804.4 29,891.8 1,935.8 288.2 20.6 29.8 103.7 22.3
403.4 16,284.0 3,600.2 221.0 9.7 5.6 73.7 3.4
1,977.1 32,103.6 3,564.0 414.0 15.3 8.4 78.5 6.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Bacil Pharma

Bacil Pharma Limited manufactures and sells pharmaceuticals, medicinal chemicals, and botanical products. The company was incorporated in 1987 and is based in Mumbai, India.

  • Incorporated

    1987

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.bacilpharma.co.in

FAQs for Bacil Pharma

The share price of Bacil Pharma Ltd is ₹12.00 (BSE) as of 28-Aug-2026 IST. Bacil Pharma Ltd has given a return of 13.44% in the last 3 years.

The P/E ratio of Bacil Pharma Ltd is 26.18 times as on 28-Aug-2026, a 34 discount to its peers’ median range of 39.90 times.
The P/B ratio of Bacil Pharma Ltd is 0.68 times as on 28-Aug-2026, a 84 discount to its peers’ median range of 4.23 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
140.14
2.28
2024
0.00
14.96
2023
0.00
6.98
2022
0.00
5.75
2021
0.00
2.44

The 52-week high and low of Bacil Pharma Ltd are Rs 61.80 and Rs 10.65 as of 29-Aug-2026.

Bacil Pharma Ltd has a market capitalisation of ₹ 17 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Bacil Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...